ARTICLE | Clinical News
Amphinex: Interim Phase I/II data
January 25, 2010 8:00 AM UTC
Interim data from 7 patients in the second dose group of a dose-escalation, U.K. Phase I/II trial showed that IV Amphinex plus bleomycin chemotherapy eliminated 100% of tumors within 2-4 weeks of trea...